Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study — Yunnan Province, China, 2021–2022

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Neutralization levels induced by inactivated vaccines rapidly wane after primary immunization, and a homologous booster can recall specific immune memory, resulting in a remarkable increase in antibody concentration. The optimal interval between primary and bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Haitao, Meng, Xing, Zhuang, Tingyu, Wang, Cangning, Yang, Zhongliang, Zhu, Taotao, Li, Mei, Zheng, Yan, Wu, Qianhui, Hu, Yaling, Yu, Hongjie, Liu, Xiaoqiang, Zeng, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061759/
https://www.ncbi.nlm.nih.gov/pubmed/37008828
http://dx.doi.org/10.46234/ccdcw2023.023

Ejemplares similares

Ejemplares similares